Cite
The recurrence of prolactinoma after withdrawal of dopamine agonist: a systematic review and meta-analysis
MLA
Yunzhi Zou, et al. “The Recurrence of Prolactinoma after Withdrawal of Dopamine Agonist: A Systematic Review and Meta-Analysis.” BMC Endocrine Disorders, vol. 21, no. 1, Nov. 2021, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s12902-021-00889-1.
APA
Yunzhi Zou, Depei Li, Jiayu Gu, Siyu Chen, Xia Wen, Jiajun Dong, & Xiaobing Jiang. (2021). The recurrence of prolactinoma after withdrawal of dopamine agonist: a systematic review and meta-analysis. BMC Endocrine Disorders, 21(1), 1–9. https://doi.org/10.1186/s12902-021-00889-1
Chicago
Yunzhi Zou, Depei Li, Jiayu Gu, Siyu Chen, Xia Wen, Jiajun Dong, and Xiaobing Jiang. 2021. “The Recurrence of Prolactinoma after Withdrawal of Dopamine Agonist: A Systematic Review and Meta-Analysis.” BMC Endocrine Disorders 21 (1): 1–9. doi:10.1186/s12902-021-00889-1.